# Software Treatment for Actively Reducing Severity of ADHD - Follow Up

> **NCT02828644** · NA · COMPLETED · sponsor: **Akili Interactive Labs, Inc.** · enrollment: 175 (actual)

## Conditions studied

- Attention Deficit Disorder With Hyperactivity

## Interventions

- **DEVICE:** EVO

## Key facts

- **NCT ID:** NCT02828644
- **Lead sponsor:** Akili Interactive Labs, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-12
- **Final completion:** 2018-02
- **Target enrollment:** 175 (ACTUAL)
- **Last updated:** 2019-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02828644

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02828644, "Software Treatment for Actively Reducing Severity of ADHD - Follow Up". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02828644. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*